Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
244 Leser
Artikel bewerten:
(1)

Future Market Insights Predicts Robust Growth for Fertility Test Market, CAGR of 7.9% from 2024 to 2034

Latest report paints a promising picture for the fertility testing market, fueled by rising infertility rates, technological advancements, and delayed parenthood. However, a lack of awareness poses a potential challenge. Read the full report today and unlock the potential of this dynamic market.

NEWARK, Del., Feb. 6, 2024 /PRNewswire/ -- The fertility test market is expected to be valued at US$ 548.4 million in 2024 and is anticipated to experience robust growth from 2024 to 2034, exhibiting a CAGR of 7.9%. Future Market Insight's projections indicate that by 2034, the market is poised to surpass the US$ 1.2 billion mark.

Future Market Insights Logo

Request Exclusive Sample Report: Fertility Test Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18940

In addition to rising infertility rates, there has been growing awareness about fertility testing options. More people are becoming educated on the importance of fertility testing and the benefits it can provide. This has led to an increased demand for fertility testing services as more individuals seek to take control of their reproductive health and make informed decisions about family planning.

The increasing adoption of advanced technologies in fertility testing has also been observed. Technological advancements in the field of fertility testing have made it possible to conduct tests more accurately and efficiently, leading to higher success rates.

The growing trend of delayed pregnancies is becoming more prevalent. Many people are choosing to postpone starting a family until later in life, which can increase the risk of fertility issues. Nowadays, many people seek to understand their fertility status and take appropriate measures to preserve their reproductive health. Consequently, there is a growing demand for fertility testing services.

Many people, however, are still uninformed about the importance of fertility testing and the available options. As a result, there can be a low demand for fertility testing services. This lack of awareness could potentially hinder the growth of the fertility test market. It is important for individuals to understand the benefits of undergoing such tests and to prioritize their reproductive health.

"As more people seek to take control of their reproductive health and make informed decisions about family planning, the demand for fertility testing services is expected to continue to grow in the coming years," says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Key Takeaways from the Fertility Test Market

  • The fertility test industry in South Korea is predicted to rise considerably, exhibiting a remarkable 9.8% CAGR through 2034.
  • The fertility test industry in Japan is predicted to develop at a CAGR of 9.3% through 2034.
  • The fertility test industry in the United Kingdom is projected to inflate at a CAGR of 9.1% through 2034.
  • The fertility test industry in China is predicted to rise at an 8.7% CAGR through 2034.
  • The fertility test market in the United States has the potential to increase at a 7.6% CAGR through 2034.
  • The ovulation prediction kit segment is anticipated to dominate the market by registering a 7.7% CAGR from 2024 to 2034.
  • With a 7.4% market CAGR, the saliva segment is likely to drive the market through 2034.

Competitive Landscape

There are a number of companies competing in the fertility test market, offering a diverse range of products and services that include prediction kits, sperm count tests, and more. With the help of cutting-edge technology like artificial intelligence and machine learning, many new players are developing advanced fertility testing solutions. Some prominent companies in the market are Clearblue, First Response, Mira, AVA, Modern Fertility, LetsGetChecked, Proov, Ovuline, YO Home Sperm Test, and Fertility Focus.

Key Fertility Test Market Players

  • learblue
  • First Response
  • Mira
  • AVA
  • Modern Fertility
  • LetsGetChecked
  • Proov
  • Ovuline
  • YO Home Sperm Test
  • Fertility Focus
  • ExSeed Health
  • Sema4
  • Roche
  • Thermo Fisher Scientific
  • Quest Diagnostics

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

Recent Developments in the Fertility Test Market

  • In March 2020, Proov received FDA approval for its at-home ovulation testing kit. Individuals can request the kit, receiving test strips that detect the presence of the progesterone metabolite PdG in urine, a key indicator of a woman's ovulation cycle.
  • In July 2021, India IVF Clinic introduced a groundbreaking do-it-yourself semen testing kit. Upon registration for semen analysis, the kit is dispatched to his residential address.

Key Fertility Test Market Segments

By Product:

  • Ovulation prediction kit
  • Male fertility testing products
  • Fertility monitor
  • Others

By Sample:

  • Saliva
  • Blood
  • Urine
  • Others

By Mode of Purchase:

  • Over the counter
  • Prescription based

By Application:

  • Female
  • Male

By End User:

  • Hospitals
  • Homecare settings
  • Fertility clinics
  • Others

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia
  • Europe
  • Oceania
  • MEA

Request to Access the Detail Research Methodology from here.

About the Author:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI's Extensive Coverage in the Healthcare Domain:

  • Fertility and Pregnancy Rapid Test Kit Market Analysis by Pregnancy Rapid Tests and Fertility Rapid Tests from 2023 to 2033. - Review and Request to Access the Sample PDF.
  • Infertility Treatment Market By Product, Procedure, Patient Type, End-Use & Region | Forecast 2022 to 2032. - Review and Request to Access the Sample PDF.
  • Dental Hygiene Instrument Market Forecast by Periodontal Probes and Dental Handpieces from 2024 to 2034. - Review and Request to Access the Sample PDF.
  • Automated Cell Shakers Market Forecast by Orbital Shakers and Accessories from 2024 to 2034. - Review and Request to Access the Sample PDF.
  • Demand Forecast for Expectorant Drugs, by Secretion Enhancers and Over-the-Counter (OTC) Medicines from 2024 to 2034. - Review and Request to Access the Sample PDF.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and market analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/future-market-insights-predicts-robust-growth-for-fertility-test-market-cagr-of-7-9-from-2024-to-2034--302054310.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.